Chitin, Chitosan and Chitosan oligosaccharides-based Biomaterials: A Comprehensive Review on Biomedical Applications.

IF 3.2 4区 医学 Q2 PHARMACOLOGY & PHARMACY
Kavita Verma, Priyanka, Neelam Yadav
{"title":"Chitin, Chitosan and Chitosan oligosaccharides-based Biomaterials: A Comprehensive Review on Biomedical Applications.","authors":"Kavita Verma, Priyanka, Neelam Yadav","doi":"10.2174/0113816128490186260908051930","DOIUrl":null,"url":null,"abstract":"<p><p>The use of chitin, chitosan, and Chitooligosaccharides (COS) has advanced rapidly in recent years due to their exceptional physicochemical and biological characteristics. Because of their biocompatibility, biodegradability, low toxicity, and functional flexibility, chitin and chitosan have attracted significant interest from the biomedical, pharmaceutical, agrochemical, culinary, and cosmetic sectors. Tissue engineering, wound healing, medication delivery, and the creation of bioactive substances with antibacterial and antiinflammatory properties are among their uses. When compared to their parent polymers, chitooligosaccharides- low-molecular-weight derivatives of chitosan with a degree of polymerization below 20-show better biological activity and water solubility. Numerous pharmacological benefits, including antioxidant, antiinflammatory, anti-obesity, anti-cancer, neuroprotective, cardioprotective, and anti-aging properties, are demonstrated by COS. Although preclinical research presently provides the majority of the data, these bioactivities make COS attractive candidates for treatments in a variety of disorders. Chemical processes that are frequently toxic to the environment and challenging to regulate with respect to polymerization and acetylation levels have historically been used to produce chitosan and COS. In order to produce well-defined products with enhanced functional properties, recent research has concentrated on enzymatic methods utilizing chitinases, chitosanases, and chitin deacetylases. This review emphasizes recent advancements in our understanding of the structural, physicochemical, and bioactive aspects of chitin-based derivatives and discusses both traditional and novel synthesis methods. Additionally, it highlights the necessity for further in vivo and translational research to fully realize the therapeutic potential of chitosan-based bioactive molecules by examining their creative uses in a variety of fields.</p>","PeriodicalId":10845,"journal":{"name":"Current pharmaceutical design","volume":" ","pages":""},"PeriodicalIF":3.2000,"publicationDate":"2026-09-16","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Current pharmaceutical design","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.2174/0113816128490186260908051930","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PHARMACOLOGY & PHARMACY","Score":null,"Total":0}
引用次数: 0

Abstract

The use of chitin, chitosan, and Chitooligosaccharides (COS) has advanced rapidly in recent years due to their exceptional physicochemical and biological characteristics. Because of their biocompatibility, biodegradability, low toxicity, and functional flexibility, chitin and chitosan have attracted significant interest from the biomedical, pharmaceutical, agrochemical, culinary, and cosmetic sectors. Tissue engineering, wound healing, medication delivery, and the creation of bioactive substances with antibacterial and antiinflammatory properties are among their uses. When compared to their parent polymers, chitooligosaccharides- low-molecular-weight derivatives of chitosan with a degree of polymerization below 20-show better biological activity and water solubility. Numerous pharmacological benefits, including antioxidant, antiinflammatory, anti-obesity, anti-cancer, neuroprotective, cardioprotective, and anti-aging properties, are demonstrated by COS. Although preclinical research presently provides the majority of the data, these bioactivities make COS attractive candidates for treatments in a variety of disorders. Chemical processes that are frequently toxic to the environment and challenging to regulate with respect to polymerization and acetylation levels have historically been used to produce chitosan and COS. In order to produce well-defined products with enhanced functional properties, recent research has concentrated on enzymatic methods utilizing chitinases, chitosanases, and chitin deacetylases. This review emphasizes recent advancements in our understanding of the structural, physicochemical, and bioactive aspects of chitin-based derivatives and discusses both traditional and novel synthesis methods. Additionally, it highlights the necessity for further in vivo and translational research to fully realize the therapeutic potential of chitosan-based bioactive molecules by examining their creative uses in a variety of fields.

几丁质、壳聚糖及壳寡糖基生物材料:生物医学应用综述。
几丁质、壳聚糖和壳寡糖(COS)由于其独特的物理化学和生物学特性,近年来得到了迅速的发展。由于甲壳素和壳聚糖具有生物相容性、可生物降解性、低毒性和功能柔韧性等特点,已引起生物医学、制药、农化、烹饪和化妆品等领域的广泛关注。组织工程、伤口愈合、药物输送以及具有抗菌和抗炎特性的生物活性物质的创造都是它们的用途。壳寡糖是壳聚糖的低分子量衍生物,聚合度在20以下,与它们的母体聚合物相比,具有更好的生物活性和水溶性。许多药理益处,包括抗氧化、抗炎、抗肥胖、抗癌、神经保护、心脏保护和抗衰老特性,都被COS证明了。尽管目前临床前研究提供了大部分数据,但这些生物活性使COS成为治疗各种疾病的有吸引力的候选药物。化学过程通常对环境有毒,并且在聚合和乙酰化水平方面具有挑战性,历史上已用于生产壳聚糖和COS。为了生产具有增强功能特性的明确产品,最近的研究集中在利用几丁质酶、几丁聚糖酶和几丁质去乙酰化酶的酶促方法上。本文着重介绍了几丁质衍生物在结构、物理化学和生物活性方面的最新进展,并讨论了传统的和新的合成方法。此外,它强调了进一步的体内和转化研究的必要性,以充分实现壳聚糖为基础的生物活性分子的治疗潜力,通过检查其在各种领域的创造性用途。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
6.30
自引率
0.00%
发文量
302
审稿时长
2 months
期刊介绍: Current Pharmaceutical Design publishes timely in-depth reviews and research articles from leading pharmaceutical researchers in the field, covering all aspects of current research in rational drug design. Each issue is devoted to a single major therapeutic area guest edited by an acknowledged authority in the field. Each thematic issue of Current Pharmaceutical Design covers all subject areas of major importance to modern drug design including: medicinal chemistry, pharmacology, drug targets and disease mechanism.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信
小红书